α-Tocopherol modulates lipoprotein cytotoxicity in obstructive nephropathy

Pediatric Nephrology

Volumn 14, Issue 8-9, 2000, Pages 740-746

  Saborio, Pablo ^a   Krieg Jr , Richard J ^a   Kuemmerle, Nancy B ^a   Norkus, Edward P ^b   Schwartz, Charles C ^a   Chan, James C M ^a,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Malondialdehyde; Oxidized low density lipoprotein; Transforming growth factor 1; Unilateral ureteral obstruction; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; LIPOPROTEIN; MALONALDEHYDE; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOTOXICITY; GLOMERULOPATHY; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY TUBULE DISORDER; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; URETER OBSTRUCTION;

EID: 0033927177     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00013428     Document Type: Article

References (51)

1. Kuemmerle NB, Brandt RB, Chan W. Krieg RJ Jr, Chan JCM (1997) Inhibition of transforming growth factor β1 induction by dietary vitamin E in unilateral ureteral obstruction in rats. Biochem Mol Med 61:82-86
2. Ricardo SD, Ding G, Eufemio M, Diamond JR (1997) Antioxidant expression in experimental hydronephrosis: role of mechanical stretch and growth factors. Am J Physiol Ren Physiol 41:F789-F798
3. Morrissey J, Windus D, Schwav S, Tannenbaum J, Klahr S (1986) Ureteral occlusion decreases phospholipid and cholesterol of renal tubular membranes. Am J Physiol 250:F136-F143
4. Tannenbaum J, Purkerson ML, Klahr S (1983) Effect of unilateral ureteral obstruction on metabolism of renal lipids in the rat. Am J Physiol 245:F254-262
5. Modi KS, Morrissey J, Shah SV, Schreiner GF, Klahr S (1990) Effects of probucol on renal function in rats with bilateral ureteral obstruction. Kidney Int 38:843-850
6. Comai K, Farber SJ, Paulsrud JR (1975) Analysis of renal medullary lipid droplets from normal, hydronephrotic and indomethacin treated rabbits. Lipids 10:555-561
7. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D (1986) Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 77:641-644
8. Lee HS, Jeong JY. Kim BC, Kim YS, Zhang YZ, Chung HK (1997) Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Kidney Int 51:1151-1159
9. Kamanna VS, Pai R, Ha H, Kirschenbaum MA, Roh DD (1999) Oxidized low-density lipoprotein stimulates monocyte adhesion to glomerular endothelial cells. Kidney Int 55: 2192-2202
10. Hessler JR, Morel DW, Lewis J, Chisolm GM (1983) Lipoprotein oxidation and lipoprotein induced cytotoxicity. Arteriosclerosis 3:215-222
11. Morel DW, Chisolm GM (1989) Antioxidant treatment of diabetic rat inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 30:1827-1834
12. Chan W, Krieg RJ, Norkus EP, Chan JCM (1998) Alpha-tocopherol reduces proteinuria, oxidative stress and expression of transforming growth factor beta 1 in IgA nephropathy in the rat. Mol Genet Metab 63:224-229
13. Konneh MK, Rutherford C, Anggard E, Ferns GA (1995) Tissue distribution of alpha-tocopherol following dietary supplementation in the rat: effects of concomitant cholesterol feeding. Proc Soc Exp Biol Med 210:156-161
14. Brandt RB, Kaugars GE, Riley WT, Bei RA, Silverman S Jr, Lovas JGL, Dezzutti BP, Chan W (1996) Evaluation of serum and tissue levels of alpha tocopherol. Biochem Mol Med 57: 64-66
15. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475
16. Havel RJ, Eder HA. Bragdon JH (1955) The distribution of chemical composition of ultracentrifugically separated lipoproteins in human serum. J Clin Invest 34:1345-1353
17. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
18. Noble RP (1973) Electrophoretic separation of plasma lipoproteins in agarose gel: J Lipid Res 9:693-700
19. Coffey MD, Cole RA, Colles SM, Chisolm GM (1995) In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. J Clin Invest 96:1866-1873
20. Mossman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
21. Chan W, Valerie KC, Chan JCM (1993) Expression of insulinlike growth factor-1 in uremic rats: growth hormone resistance and nutritional intake. Kidney Int 43:790-795
22. Warshaw BL, Edelbrock HH, Ettenger RB, Malekzadeh MH, Pennisi AJ, Uittenbogaart CH, Fine RN (1982) Progression to end-stage renal disease in children with obstructive uropathy. J Pediatr 100:183-187
23. Warshaw BL, Edelbrock HH, Ettenger RB, Malekzadeh MH, Pennisi AJ, Uittenbogaart CH, Fine RN (1980) Renal transplantation in children with obstructive uropathy. J Urol 123:737-741
24. Chevalier RL, Gomez RA (1994) Obstructive uropathy: pathophysiology. In: Holliday MA. Barratt TM, Avner ED (eds) Pediatric nephrology. Williams and Wilkins, Baltimore, pp 994-1005
25. Drozdz D, Drozdz M, Gretz N, Mohring K, Mehls O, Schärer K (1998) Progression to end-stage renal disease in children with posterior urethral valves. Pediatr Nephrol 12:630-636
26. Peters CA (1998) Lower urinary tract obstruction: clinical and experimental aspects. Br J Urol 81:22-32
27. Steinberg D, Parthasanathy TE, Carew T, Knoo JC, Witztum JC (1989) Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924
28. Rangaswamy S, Penn MS, Saidel GM, Chisolm GM (1997) Exogenous oxidized low density lipoprotein injures and alters the barrier function of endothelium in rats in vivo. Circ Res 80:37-44
29. Magil AB, Frohlich JJ, Innis SM, Steinbrecher UP (1993) Oxidized low density lipoprotein in experimental focal glomerulo-sclerosis. Kidney Int 43:1243-1250
30. Keane WF, Kasiske BL, O'Donnell MP, Kim Y (1991) The role of altered lipid metabolism in the progression of renal disease: experimental evidence. Am J Kidney Dis 17:38-42
31. Moorhead JF, Wheeler DC, Varghese Z (1989) Glomerular structures and lipids in progressive renal disease. Am J Med 87: 5N-12N
32. Al-Shebeb T, Frohlich J, Magil AB (1988) Glomerular disease in hypercholesterolemic guinea pigs: a pathoaenic study. Kidney Int 33:498-507
33. Wheeler DC, Bernard DB (1994) Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment. Am J Kidney Dis 23:331-346
34. Eddy AA (1996) Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia. Kidney Int 50:1139-1149
35. Wheeler DC, Chana RS (1993) Interactions between lipoproteins, glomerular cells and matrix. Miner Electrolyte Metab 19:149-164
36. Grond J, Goor H van, Erkelens DW, Elema JD (1986) Glomerular sclerotic lesions in the rat. Histochemical analysis of their macromolecular and cellular composition. Virchows Arch B 51: 521-534
37. Van Goor H, Horst MLC van der, Atmosoerodjo J, Joles JA, Tol J van, Grond J (1993) Renal apolipoproteins in nephrotic rats. Am J Pathol 142:1804-1812
38. Wheeler DC, Chana RS, Topley N, Petersen MM, Davies M, Williams JD (1991) Contrasting effects of native and oxidized LDL on human mesangial cell growth and eicosanoid production (abstract). J Am Soc Nephrol 2:567
39. Nath KA, Croatt AJ, Hostetter TH (1990) Oxygen consumption and oxidant stress in surviving nephrons. Am J Physiol 258:F1354-F1362
40. Fernando RL, Varghese Z, Moorhead JF (1998) Differential ability of cells to promote oxidation of low-density lipoprotein in vitro. Clin Chim Acta 269:159-173
41. Gotoda T, Arita M, Arai H, Inoue K, Yokota T, Fukuo Y, Yazaki Y, Yamada N (1995) Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein. N Engl J Med 333:1313-1318
42. Spielberg SP, Boxer A, Corash LM, Schulman JD (1979) Improved erythrocyte survival with high-dose vitamin E in glutathione synthetase deficiencies. Ann Intern Med 90:53-54
43. Trachtman H, Del Pizzo R, Futterweit S, Levine D, Rao PS, Valderrama E, Sturman JA (1992) Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. Am J Physiol 262:F117-F123
44. Trachtman H, Chan JCM, Chan W, Valderrama E, Brandt R, Wakely P, Futterweit S, Maesaka J, Ma C (1996) Vitamin E ameliorates renal injury in an experimental model of immunoglobulin A nephropathy. Pediatr Res 40:620-626
45. Trachtman H, Schwob N (1993) Administration of vitamin E attenuates chronic puromycin aminonucleoside nephropathy. J Am Soc Nephrol 4:785-790
46. Ueda N, Baliga R, Shah SV (1997) In vivo evidence for a role of reactive oxygen metabolites in glomerular disease. Kidney 6:143-146
47. Craven PA, Derubertis FR, Kagan VE, Melhem M, Studer RK (1997) Effects of supplementation with vitamin C or E on albuminuria, glomerular TGFβ, and glomerular size in diabetes. J Am Soc Nephrol 8:1405-1414
48. Lee HS, Kim BC, Kim YS, Choi KH, Chung HK (1996) Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells. Kidney Int 50:1582-1590
49. Richard MJ, Arnaud J, Jurkovitz C, Hachache R, Meftahi H, Laporte F, Foret M, Favier A, Cordonnier D (1991) Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 57:10-15
50. Rajbala A, Sane AS, Zope J, Mishra VV, Trivedi HL (1997) Oxidative stress status in children with nephrotic syndrome. Panminerva Med 39:165-168
51. Johnson GC, Bauer FC, Hirsch EF, Carbonaro L (1951) Lipemia of rabbits following unilateral occlusion of the renal vessels. A M A Arch Pathol 52:115-118